Haemonetics Corp.
HAE
Market Cap$3.55B
Close$
$169.08
129.1% upside
Current Fair Value
129.1% upsideUndervalued by 129.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.55 Billion |
|---|---|
| Enterprise Value | $4.46 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.31 |
| Beta | 0.37 |
| Outstanding Shares | 49,193,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.65 |
|---|---|
| PEG | 11.72 |
| Price to Sales | 2.73 |
| Price to Book Ratio | 3.88 |
| Enterprise Value to Revenue | 3.28 |
| Enterprise Value to EBIT | 19.71 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 1.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon